Estados financieros detallados de Moleculin Biotech, Inc. (MBRX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.74, MBRX presenta beneficios negativos (P/E no significativo) y un ROE del -8.17%. La capitalización bursátil es de $4M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $6162 | $18000 | $68000 | $185000 | 0 | 0 | 0 | 0 | 0 | $90000 |
| Beneficio Bruto | -$6162 | -$18000 | -$68000 | -$185000 | 0 | 0 | 0 | 0 | 0 | -$90000 |
| I+D | $1.5M | $4.5M | $9.7M | $11.0M | $12.8M | $14.4M | $19.0M | $19.5M | $17.7M | $15.9M |
| Generales y Administrativos | $2.4M | $4.1M | $5.3M | $6.3M | $6.8M | $8.4M | $11.5M | $10.0M | $8.8M | $9.1M |
| Gastos Operativos | $3.9M | $8.7M | $15.0M | $17.3M | $19.7M | $23.0M | $30.6M | $29.6M | $26.6M | $25.1M |
| Beneficio Operativo | -$3.9M | -$8.7M | -$15.0M | -$17.5M | -$19.7M | -$23.0M | -$30.6M | -$29.6M | -$26.6M | -$25.1M |
| EBITDA | -$3.9M | -$8.6M | -$15.0M | -$13.2M | -$19.5M | -$15.7M | -$28.9M | -$29.6M | -$21.6M | -$33.5M |
| Gastos por Intereses | $43214 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$3.9M | -$9.8M | -$11.9M | -$13.4M | -$17.4M | -$15.9M | -$29.0M | -$29.8M | -$21.8M | -$33.6M |
| Impuestos | 0 | 0 | 0 | -$229000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$3.9M | -$9.8M | -$11.9M | -$13.2M | -$17.4M | -$15.9M | -$29.0M | -$29.8M | -$21.8M | -$33.6M |
| BPA | $-900.00 | $-1188.07 | $-1031.54 | $-729.63 | $-661.00 | $-221.77 | $-380.51 | $-376.71 | $-189.14 | $-28.42 |
| BPA Diluido | $-900.00 | $-1188.07 | $-1031.54 | $-729.63 | $-661.00 | $-221.77 | $-380.51 | $-376.71 | $-189.14 | $-28.42 |
| Acciones en Circulación (Diluidas) | $4367 | $8252 | $11512 | $18098 | $26255 | $71669 | $76278 | $79024 | $137720 | $1.2M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.0M | $7.7M | $7.1M | $10.7M | $15.2M | $70.9M | $43.1M | $23.6M | $4.3M | $8.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $56000 | $11000 | $1000 | $45000 | 0 | 0 | 0 | $7000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $5.2M | $8.3M | $8.0M | $13.5M | $17.2M | $72.5M | $45.6M | $26.3M | $5.2M | $9.7M |
| Inmovilizado Material | $23128 | $33000 | $463000 | $603000 | $685000 | $445000 | $678000 | $796000 | $583000 | $314000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M |
| Activos Totales | $16.4M | $19.5M | $19.6M | $25.2M | $29.2M | $84.1M | $57.4M | $38.2M | $16.9M | $22.1M |
| Cuentas por Pagar | $399000 | $810000 | $1.2M | $2.2M | $1.1M | $1.4M | $2.1M | $2.5M | $2.0M | $3.5M |
| Deuda a Corto | $296000 | 0 | 0 | $103000 | $118000 | $96000 | 0 | 0 | 0 | $137000 |
| Pasivos Corrientes | $1.3M | $2.2M | $3.9M | $3.6M | $2.9M | $3.6M | $4.8M | $6.8M | $5.4M | $6.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.4M | $2.4M | $5.3M | $9.7M | $11.3M | $5.1M | $5.2M | $12.1M | $10.9M | $7.1M |
| Reservas | -$4.7M | -$14.5M | -$26.4M | -$39.6M | -$56.9M | -$72.8M | -$101.8M | -$131.6M | -$153.4M | -$206.0M |
| Patrimonio Neto | $15.0M | $17.1M | $14.3M | $15.6M | $17.9M | $79.0M | $52.2M | $26.1M | $6.0M | $15.0M |
| Deuda Total | $296412 | 0 | 0 | $379000 | $277000 | $159000 | $451000 | $574000 | $478000 | $359000 |
| Deuda Neta | -$4.7M | -$7.7M | -$7.1M | -$10.4M | -$14.9M | -$70.7M | -$42.7M | -$23.0M | -$3.8M | -$8.5M |
| Capital Circulante | $3.9M | $6.1M | $4.1M | $9.9M | $14.3M | $68.9M | $40.8M | $19.5M | -$165000 | $2.8M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$3.9M | -$9.8M | -$11.9M | -$13.2M | -$17.4M | -$15.9M | -$29.0M | -$29.8M | -$21.8M | -$33.6M |
| Amortizaciones | $6162 | $18000 | $68000 | $199000 | $200000 | $164000 | $130000 | $127000 | $126000 | $90000 |
| Compensación en Acciones | $411474 | $707000 | $1.1M | $1.5M | $1.7M | $2.4M | $2.3M | $2.0M | $1.7M | $1.7M |
| Cambio en Capital Circulante | -$256180 | $542000 | $1.6M | -$2.1M | -$41000 | $1.0M | $224000 | $1.6M | $231000 | $555000 |
| Flujo de Caja Operativo | -$3.8M | -$7.3M | -$12.2M | -$17.2M | -$17.8M | -$19.0M | -$27.6M | -$24.1M | -$23.9M | -$22.7M |
| Inversiones (CapEx) | -$21470 | -$28000 | -$417000 | -$52000 | -$376000 | -$19000 | -$67000 | -$124000 | -$13000 | 0 |
| Adquisiciones | -$99638 | 0 | 0 | 0 | $2000 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | -$23000 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.8M | -$7.4M | -$12.6M | -$17.2M | -$18.1M | -$19.0M | -$27.7M | -$24.2M | -$23.9M | -$22.7M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | -149.7% | -21.1% | -11.2% | -31.4% | +8.4% | -82.6% | -2.6% | +26.9% | -54.2% | |
| Crecimiento BPA (anual) | -32.0% | +13.2% | +29.3% | +9.4% | +66.4% | -71.6% | +1.0% | +49.8% | +85.0% | |
| Cambio en Acciones (anual) | +89.0% | +39.5% | +57.2% | +45.1% | +173.0% | +6.4% | +3.6% | +74.3% | +760.1% | |
| Crecimiento FCF (anual) | -94.2% | -71.7% | -36.7% | -5.2% | -4.5% | -46.1% | +12.6% | +1.4% | +4.8% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | 1.7% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-867.04 | $-890.94 | $-1096.25 | $-953.14 | $-691.18 | $-264.69 | $-363.22 | $-306.55 | $-173.36 | $-19.19 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $4367 | $8252 | $11512 | $18098 | $26255 | $71669 | $76278 | $79024 | $137720 | $1.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -816.56% |
| Rentabilidad sobre capital invertido | -242.25% |
| Rentabilidad sobre activos | -143.82% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.03 |
| Ratio corriente | 0.94 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -5.70 | -3.52 | -2.27 | -2.82 | -2.71 | -3.15 | -1.04 | -0.85 | -0.22 | -0.12 |
| P/VC | 1.50 | 2.02 | 1.89 | 2.39 | 2.63 | 0.63 | 0.58 | 0.98 | 0.98 | 0.26 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ADAP · AIMD · APLM · ATHA · BLRX · CTXR · ICU
Explorar sector: Healthcare · Biotechnology
Más secciones de MBRX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones